Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Cardioprotective Effects of Salvia Miltiorrhiza Radix on the Pressure Overloaded Heart Failure Model by Transverse Aortic Constriction-induced Mice

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2016, v.37 no.2, pp.23-35



  • Downloaded
  • Viewed

Abstract

Objectives: The objective of this study is to demonstrate the cardioprotective effects of Salvia Miltiorrhiza Radix (SMR) on the pressure overload (PO)-induced heart failure (HF) by transverse aortic constriction (TAC) in C57BL/6 mice through possible antioxidant effects. Methods: The mortality, body and heart weights, antioxidant defense system of the heart and histopathology of heart were analyzed. The obtained results were compared with resveratrol, in which potent cardioprotective effects on TAC mice model were already proved at a dose level of 10 mg/kg by antioxidant effects, as reference in this experiment. Results: Significant increases of mortalities, heart weights, and hypertrophic, lytic and focal fibrotic histological changes in the left ventricles were found with defects of heart antioxidant defense systems – the increases of heart cortex MDA contents, decreases of GSH contents, SOD and CAT activities in TAC control mice as compared with sham vehicle control mice, respectively. However, these HF signs induced by TAC surgery through PO and destroys heart antioxidant defense systems were significantly and dose-dependently inhibited by 14 days continuous oral treatment of SMR 500, 250 and 125 mg/kg, similar to those of resveratrol 10 mg/kg in SMR 125 mg/kg. Conclusions: The results obtained in this study propose that oral administration of SMR potently alleviates PO-induced HF by TAC, through augmentation of heart antioxidant defense system.

keywords
Cardioprotective Effects, Salvia Miltiorrhiza Radix, Pressure Overloaded Heart Failure


Reference

1

1. Juric D, Wojciechowski P, Das DK, Netticadan T. Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol. Am J Physiol Heart Circ Physiol. 2007;292: 2138-43.

2

2. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45-79.

3

3. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2011ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 2011;58:e212-60.

4

4. Yu S, Li G. MicroRNA expression and function in cardiac ischemic injury. J Cardiovasc. Transl. Res. 2010;3(3):241-5.

5

5. Saletu B, Paulus E, Linzmayer L, Anderer P, Semlitsch HV, Grünberger J, et al. Nicergoline in senile dementia of Alzheimer type and multi -infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study. Psychopharmacology. 1995;117(4):385-95.

6

6. Yu S, Kuang P, Kanazawa T, Onodera K, Metoki H, Oike Y. The effects of radix Salviae miltiorrhizae on lipid accumulation of peroxidized low density lipoprotein in mouse peritoneal macrophages-lipid analysis and morphological studies. J. Tradit. Chin. Med. 1998;18(4):292-9.

7

7. Ge G, Zhang Q, Ma J, Qiao Z, Huang J, Cheng W, et al. Protective effect of Salvia miltiorrhiza aqueous extract on myocardium oxidative injury in ischemic-reperfusion rats. Gene. 2014;546(1):97-103.

8

8. Gao Y, Zhang K, Zhu F, Wu Z, Chu X, Zhang X, et al. Salvia miltiorrhiza (Danshen) inhibits L-type calcium current and attenuates calcium transient and contractility in rat ventricular myocytes. J. Ethnopharmacol. 2014;158(Part A):397-403.

9

9. Geng ZH, Huang L, Song MB, Song YM. Protective effect of a polysaccharide from Salvia miltiorrhiza on isoproterenol (ISO)-induced myocardial injury in rats. Carbohydr. Polym. 2015;132:638-42.

10

10. Gupta PK, DiPette DJ, Supowit SC. Protective effect of resveratrol against pressure overload -induced heart failure. Food Sci. Nutr. 2014;2:218-29.

11

11. Qi J, Liu Q, Gong K, Yu J, Wang L, Guo L, et al. Apocynum tablet protects against cardiac hypertrophy via inhibiting AKT and ERK1/2phosphorylation after pressure overload. Evid. Based Complement Alternat. Med. 2014;2014:1-9.

12

12. Kim HS, Park SI, Choi SH, Song CH, Park SJ, Shin YK, et al. Single oral dose toxicity test of blue honeysuckle concentrate in mice. Toxicol. Res. 2015;31(1):61-8.

13

13. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193(1):265-75.

14

14. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990;186:421-31.

15

15. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105;121-6.

16

16. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 1969;27(3):502-22.

17

17. Levene A. Pathological factors influencing excision of tumours in the head and neck. Part I. Clin. Otolaryngol. Allied Sci. 1981;6(2):145-51.

18

18. Ludbrook J. Update: microcomputer statistics packages. A personal view. Clin. Exp. Pharmacol. Physiol. 1997;24(3-4):294-6.

19

19. Son HR. Direct medical costs for patients with heart failure disease : based on national patients sample for the national health insurance claims data[dissertation]. Gyeonggi-do: Sungkyunkwan Univ.; 2015.

20

20. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275(20):1557-62.

21

21. Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-Cintrón M, Chen T, et al. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression -induced heart failure. Circ. Res. 2011;108(7):837-46.

22

22. Oka T, Komuro I. Molecular mechanisms underlying the transition of cardiac hypertrophy to heart failure. Circ. J. 2008;72(Supplement A):A13-A16.

23

23. Rosca MG, Hoppel CL. Mitochondria in heart failure. Cardiovasc. Res. 2010;88(1):40-50.

24

24. Kim MS, Bang JH, Lee J, Kim HW, Sung SH, Han JS, et al. Salvia miltiorrhiza extract protects white matter and the hippocampus from damage induced by chronic cerebral hypoperfusion in rats. BMC. Complementary and Alternative Medicine. 2015;15:415.

25

25. Tsai CC, Chang LC, Huang SC, Tey SL, Hsu WL, Su YT et al. Salvia miltiorrhiza Induces Tonic Contraction of the Lower Esophageal Sphincter in Rats via Activation of Extracellular Ca2+ Influx. Molecules. 2015;20(8):14504-21.

26

26. Li LN. Water soluble active components of Salvia miltiorrhiza and related plants. J. Chin. Pharm. Sci. 1997;6:57-64.

27

27. Wang JM, He HB, Zhu YQ, Shi DW, Li YM, Zhang Y. Reversed phase HPLC determination of danshensu and protocatechuic aldehyde in Salvia miltiorrhiza. Acta. Acad. Med. Shanghai. 1991;18:27-32.

28

28. Kim CH, Koo BS, Kim KO, Kim JK, Chang YC, Lee IS. Salviae miltiorrhizae radix increases dopamine release of rat and pheochromocytoma PC12 cells. Phytother. Res. 2006;20(3):191-9.

29

29. Liu GT, Zhang TM, Wang BE, Wang YW. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochem. Pharmacol. 1992;43(2):147-52.

30

30. Wang J, Ma Z, Hong Z, Song J. Tissue distribution in mice of danshensu from sodium danshensu and Salvia miltiorrhiza injection. Chin. J. Chin. Mat. Med. 2011;36(11):1516-8.

31

31. Long W, Zhang SC, Wen L, Mu L, Yang F, Chen G. In vivo distribution and pharmacokinetics of multiple active components from Danshen and Sanqi and their combination via inner ear administration. J. Ethnopharmacol. 2014;156:199-208.

32

32. Van Empel VP, Bertrand AT, van Oort RJ, van der Nagel R, Engelen M, van Rijen HV, et al. EUK-8, a superoxide dismutase and catalase mimetic, reduces cardiac oxidative stress and ameliorates pressure overload-induced heart failure in the harlequin mouse mutant. J. Am. Coll. Cardiol. 2006;48(4):824-32.

33

33. Odabasoglu F, Cakir A, Suleyman H, Aslan A, Bayir Y, Halici M, et al. Gastroprotective and antioxidant effects of usnic acid on indomethacin -induced gastric ulcer in rats. J. Ethnopharmacol. 2006;103(1):59-65.

34

34. Koga K, Kenessey A, Ojamaa K. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2013;304:282-93.

35

35. Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br. Med. Bull. 1993;49(3):481-93.

36

36. Herbalogy Professors of Korean Medicine. Herbalogy. Seoul:Younglimsa. 2008:459.

37

37. Liang YC. Hypertension disease. Beijing:Hwahakgongeopmunheonchulpansa. 2003:129.

38

38. Herbal formulation Professors of Korean Medicine. Herbal formulation. Seoul:Younglimsa. 2003:329-31.

39

39. Kang CS, Jeon SY, Hong S. Effect of Hyeonsamdansameum on hypertensive rat induced monocrotaline. Korean J. Orient. Physiol. Pathol. 2008;22(5):1223-35.

40

40. Jung IC. Effects of Chenwhangbosim-dan and Sungimjihwang-tang on protecting microglia and inhibiting acetylcholinesterase and oxidants. Korean J. Orient. Physiol. Pathol. 2008;22(1):120-5.

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine